{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T17:22:45Z","timestamp":1786123365054,"version":"build-2736575974"},"reference-count":40,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2020,3]]},"abstract":"<jats:sec>\n                    <jats:title>BACKGROUND:<\/jats:title>\n                    <jats:p>The anticholinesterase neostigmine and the muscarinic inhibitor glycopyrrolate are frequently coadministered for the reversal of neuromuscular blockade. This practice can precipitate severe bradycardia or tachycardia, but whether it affects the incidence of cardiovascular complications remains unclear. We hypothesized that anticholinesterase reversal with neostigmine and glycopyrrolate versus no anticholinesterase reversal increases the risk of postoperative cardiovascular complications among adult patients undergoing noncardiac surgery with general anesthesia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS:<\/jats:title>\n                    <jats:p>We conducted a prespecified retrospective analysis of hospital registry data from a major health care network for patients undergoing surgery with general anesthesia from January 2007 to December 2015. The primary outcome was a composite of cardiac dysrhythmia, acute heart failure, transient ischemic attack, ischemic stroke, and acute myocardial infarction within 30 days after surgery. We performed sensitivity analyses in subgroups and propensity score adjustment and explored the association between exposure and outcome in subgroups of patients with high risk of cardiovascular complications.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS:<\/jats:title>\n                    <jats:p>\n                      Of the 98,147 cases receiving neuromuscular blockade, 73,181 (74.6%) received neostigmine and glycopyrrolate, while 24,966 (25.4%) did not. A total of 5612 patients (7.7%) in the anticholinesterase reversal group and 1651 (6.6%) in the control group (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; .001) experienced the primary outcome. After adjustment for clinical covariates, neostigmine and glycopyrrolate exposure was significantly associated in a dose-dependent fashion (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      for trend &lt;.001, respectively) with tachycardia (adjusted odds ratio = 2.1 [95% CI, 1.97\u20132.23];\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; .001) and bradycardia (adjusted odds ratio = 2.84 [95% CI, 2.49\u20133.24];\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; .001) but not with postoperative cardiovascular complications (adjusted odds ratio = 1.03 [95% CI, 0.97\u20131.1];\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = .33). We identified a significant effect modification of anticholinesterase reversal by high age, high-risk surgery, and history of atrial fibrillation (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      for interaction = .002, .001, and .02, respectively). By using linear combinations of main effect and exposure\u2013risk interaction terms, we detected significant associations between anticholinesterase reversal and cardiovascular complications toward a higher vulnerability in these patient subgroups.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS:<\/jats:title>\n                    <jats:p>Neuromuscular blockade reversal with neostigmine and glycopyrrolate was associated with an increased incidence of intraoperative tachycardia and bradycardia but not with 30-day postoperative cardiovascular complications. Exploratory analyses suggest that a high postoperative cardiovascular complication risk profile may modify the effects of anticholinesterase reversal toward clinical relevance.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1213\/ane.0000000000004099","type":"journal-article","created":{"date-parts":[[2019,3,25]],"date-time":"2019-03-25T17:29:05Z","timestamp":1553534945000},"page":"685-695","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":17,"title":["Effects of Anticholinesterase Reversal Under General Anesthesia on Postoperative Cardiovascular Complications: A Retrospective Cohort Study"],"prefix":"10.1213","volume":"130","author":[{"given":"Denys","family":"Shay","sequence":"first","affiliation":[{"name":"Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts"},{"name":"Department of Anesthesia, Critical Care and Pain Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flora T.","family":"Scheffenbichler","sequence":"additional","affiliation":[{"name":"Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barry J.","family":"Kelly","sequence":"additional","affiliation":[{"name":"Department of Anesthesia, Critical Care and Pain Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Louise","family":"Lihn","sequence":"additional","affiliation":[{"name":"Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Deng","sequence":"additional","affiliation":[{"name":"Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anahita","family":"Nourmahnad","sequence":"additional","affiliation":[{"name":"Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinling","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Anesthesia, Critical Care and Pain Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy T.","family":"Houle","sequence":"additional","affiliation":[{"name":"Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Eikermann","sequence":"additional","affiliation":[{"name":"Department of Anesthesia, Critical Care and Pain Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts"},{"name":"Klinik f\u00fcr An\u00e4sthesiologie und Intensivmedizin, Universit\u00e4tsklinikum Essen, Essen, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart A.","family":"Forman","sequence":"additional","affiliation":[{"name":"Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250225","doi-asserted-by":"crossref","first-page":"201","DOI":"10.2471\/BLT.15.159293","article-title":"Size and distribution of the global volume of surgery in 2012.","volume":"94","author":"Weiser","year":"2016","journal-title":"Bull World Health Organ"},{"key":"R2-20250225","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/s00464-014-3711-7","article-title":"Neuromuscular blockade improves surgical conditions (NISCO).","volume":"29","author":"Blobner","year":"2015","journal-title":"Surg Endosc"},{"key":"R3-20250225","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1213\/ANE.0b013e3181c07428","article-title":"A survey of current management of neuromuscular block in the United States and Europe.","volume":"111","author":"Naguib","year":"2010","journal-title":"Anesth Analg"},{"key":"R4-20250225","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/S0022-3565(25)38120-6","article-title":"Mechanism of the bradycardia produced in the cat by the anticholinesterase neostigmine.","volume":"265","author":"Backman","year":"1993","journal-title":"J Pharmacol Exp Ther"},{"issue":"suppl 1","key":"R5-20250225","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.1365-2044.2008.05867.x","article-title":"Antagonism of non-depolarising neuromuscular block: current practice.","volume":"64","author":"Kopman","year":"2009","journal-title":"Anaesthesia"},{"key":"R6-20250225","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1093\/bja\/55.10.955","article-title":"Pattern of change of bronchomotor tone following reversal of neuromuscular blockade. Comparison between atropine and glycopyrrolate.","volume":"55","author":"Hammond","year":"1983","journal-title":"Br J Anaesth"},{"key":"R7-20250225","first-page":"41","article-title":"Heart block and prolonged Q-Tc interval following muscle relaxant reversal: a case report.","volume":"76","author":"Shields","year":"2008","journal-title":"AANA J"},{"key":"R8-20250225","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1053\/j.jvca.2016.06.020","article-title":"Recurrent asystole after neostigmine in a heart transplant recipient with end-stage renal disease.","volume":"31","author":"Cachemaille","year":"2017","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"R9-20250225","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1093\/bja\/52.1.85","article-title":"Evaluation of glycopyrrolate and atropine as adjuncts to reversal of non-depolarizing neuromuscular blocking agents in a \u201ctrue-to-life\u201d situation.","volume":"52","author":"Cozanitis","year":"1980","journal-title":"Br J Anaesth"},{"key":"R10-20250225","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1399-6576.1982.tb01743.x","article-title":"Advantages of glycopyrrolate over atropine during reversal of pancuronium block.","volume":"26","author":"Heinonen","year":"1982","journal-title":"Acta Anaesthesiol Scand"},{"key":"R11-20250225","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1093\/bja\/83.5.815","article-title":"Development of rapid atrial fibrillation with a wide QRS complex after neostigmine in a patient with intermittent Wolff-Parkinson-White syndrome.","volume":"83","author":"Kadoya","year":"1999","journal-title":"Br J Anaesth"},{"key":"R12-20250225","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.jamcollsurg.2006.11.011","article-title":"An Apgar score for surgery.","volume":"204","author":"Gawande","year":"2007","journal-title":"J Am Coll Surg"},{"key":"R13-20250225","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1046\/j.1532-5415.2001.49212.x","article-title":"Relative importance of preoperative health status versus intraoperative factors in predicting postoperative adverse outcomes in geriatric surgical patients.","volume":"49","author":"Leung","year":"2001","journal-title":"J Am Geriatr Soc"},{"key":"R14-20250225","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/aas.12651","article-title":"Enhanced recovery after surgery (ERAS) for gastrointestinal surgery, part 2: consensus statement for anaesthesia practice.","volume":"60","author":"Feldheiser","year":"2016","journal-title":"Acta Anaesthesiol Scand"},{"key":"R15-20250225","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1213\/ANE.0000000000002742","article-title":"American Society for Enhanced Recovery and Perioperative Quality Initiative Joint Consensus Statement on postoperative gastrointestinal dysfunction within an enhanced recovery pathway for elective colorectal surgery.","volume":"126","author":"Hedrick","year":"2018","journal-title":"Anesth Analg"},{"key":"R16-20250225","doi-asserted-by":"crossref","first-page":"e297","DOI":"10.1371\/journal.pmed.0040297","article-title":"Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration.","volume":"4","author":"Vandenbroucke","year":"2007","journal-title":"PLoS Med"},{"key":"R17-20250225","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1177\/0962280206074463","article-title":"Multiple imputation of discrete and continuous data by fully conditional specification.","volume":"16","author":"van Buuren","year":"2007","journal-title":"Stat Methods Med Res"},{"key":"R18-20250225","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1097\/ALN.0000000000000440","article-title":"Effects of neostigmine reversal of nondepolarizing neuromuscular blocking agents on postoperative respiratory outcomes: a prospective study.","volume":"121","author":"Sasaki","year":"2014","journal-title":"Anesthesiology"},{"key":"R19-20250225","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1097\/ALN.0b013e318293065c","article-title":"Development and validation of a score for prediction of postoperative respiratory complications.","volume":"118","author":"Brueckmann","year":"2013","journal-title":"Anesthesiology"},{"key":"R20-20250225","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1080\/00273171.2011.568786","article-title":"An introduction to propensity score methods for reducing the effects of confounding in observational studies.","volume":"46","author":"Austin","year":"2011","journal-title":"Multivariate Behav Res"},{"key":"R21-20250225","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1002\/pds.1673","article-title":"Goodness-of-fit diagnostics for the propensity score model when estimating treatment effects using covariate adjustment with the propensity score.","volume":"17","author":"Austin","year":"2008","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"R22-20250225","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0895-4356(00)00321-8","article-title":"Validating recommendations for coronary angiography following acute myocardial infarction in the elderly: a matched analysis using propensity scores.","volume":"54","author":"Normand","year":"2001","journal-title":"J Clin Epidemiol"},{"key":"R23-20250225","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1097\/ALN.0000000000000674","article-title":"Dose-dependent association between intermediate-acting neuromuscular-blocking agents and postoperative respiratory complications.","volume":"122","author":"McLean","year":"2015","journal-title":"Anesthesiology"},{"key":"R24-20250225","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1213\/00000539-197703000-00004","article-title":"A comparison of glycopyrrolate and atropine during reversal of nondepolarizing neuromuscular block with neostigmine.","volume":"56","author":"Ostheimer","year":"1977","journal-title":"Anesth Analg"},{"key":"R25-20250225","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1093\/bja\/49.8.825","article-title":"Glycopyrrolate-neostigmine mixture for antagonism of neuromuscular block: comparison with atropine-neostigmine mixture.","volume":"49","author":"Mirakhur","year":"1977","journal-title":"Br J Anaesth"},{"key":"R26-20250225","first-page":"CD012763","article-title":"Efficacy and safety of sugammadex versus neostigmine in reversing neuromuscular blockade in adults.","volume":"8","author":"Hristovska","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"R27-20250225","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1213\/00000539-198108000-00004","article-title":"Reversal of neuromuscular blockade: dose determination studies with atropine and glycopyrrolate given before or in a mixture with neostigmine.","volume":"60","author":"Mirakhur","year":"1981","journal-title":"Anesth Analg"},{"key":"R28-20250225","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1111\/anae.14386","article-title":"Therapeutic doses of neostigmine, depolarising neuromuscular blockade and muscle weakness in awake volunteers: a double-blind, placebo-controlled, randomised volunteer study.","volume":"73","author":"Kent","year":"2018","journal-title":"Anaesthesia"},{"key":"R29-20250225","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1111\/anae.14326","article-title":"Implementation of a new strategy to improve the peri-operative management of neuromuscular blockade and its effects on postoperative pulmonary complications.","volume":"73","author":"Rudolph","year":"2018","journal-title":"Anaesthesia"},{"key":"R30-20250225","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1097\/EJA.0000000000000861","article-title":"Comparison of a novel clinical score to estimate the risk of residual neuromuscular block prediction score and the last train-of-four count documented in the electronic anaesthesia record: a retrospective cohort study of electronic data on file.","volume":"35","author":"Rudolph","year":"2018","journal-title":"Eur J Anaesthesiol"},{"key":"R31-20250225","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jclinane.2017.09.005","article-title":"Incidence of complications in the post-anesthesia care unit and associated healthcare utilization in patients undergoing non-cardiac surgery requiring neuromuscular blockade 2005-2013: a single center study.","volume":"43","author":"Belcher","year":"2017","journal-title":"J Clin Anesth"},{"key":"R32-20250225","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1213\/ane.0b013e31816d1268","article-title":"Residual neuromuscular blockade and critical respiratory events in the postanesthesia care unit.","volume":"107","author":"Murphy","year":"2008","journal-title":"Anesth Analg"},{"key":"R33-20250225","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1177\/0310057X1204000611","article-title":"A prospective, observational study comparing postoperative residual curarisation and early adverse respiratory events in patients reversed with neostigmine or sugammadex or after apparent spontaneous recovery.","volume":"40","author":"Cammu","year":"2012","journal-title":"Anaesth Intensive Care"},{"key":"R34-20250225","first-page":"735","article-title":"Prospective study of residual neuromuscular block and postoperative respiratory complications in patients reversed with neostigmine versus sugammadex.","volume":"82","author":"Martinez-Ubieto","year":"2016","journal-title":"Minerva Anestesiol"},{"key":"R35-20250225","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.redar.2012.12.011","article-title":"Residual neuromuscular block as a risk factor for critical respiratory events in the post anesthesia care unit.","volume":"60","author":"Norton","year":"2013","journal-title":"Rev Esp Anestesiol Reanim"},{"key":"R36-20250225","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jclinane.2016.05.009","article-title":"Surgical Apgar score is associated with myocardial injury after noncardiac surgery.","volume":"34","author":"House","year":"2016","journal-title":"J Clin Anesth"},{"key":"R37-20250225","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1213\/00000539-200208000-00003","article-title":"Intraoperative tachycardia and hypertension are independently associated with adverse outcome in noncardiac surgery of long duration.","volume":"95","author":"Reich","year":"2002","journal-title":"Anesth Analg"},{"key":"R38-20250225","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1097\/ALN.0000000000002107","article-title":"Etiology of acute coronary syndrome after noncardiac surgery.","volume":"128","author":"Helwani","year":"2018","journal-title":"Anesthesiology"},{"key":"R39-20250225","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/S0002-8703(03)00319-3","article-title":"Cholinergic stimulation with pyridostigmine reduces ventricular arrhythmia and enhances heart rate variability in heart failure.","volume":"146","author":"Behling","year":"2003","journal-title":"Am Heart J"},{"key":"R40-20250225","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1136\/hrt.2003.028167","article-title":"Cholinergic stimulation with pyridostigmine protects against exercise induced myocardial ischaemia.","volume":"90","author":"Castro","year":"2004","journal-title":"Heart"}],"container-title":["Anesthesia &amp; Analgesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1213\/ANE.0000000000004099","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T14:30:18Z","timestamp":1786113018000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1213\/ANE.0000000000004099"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1213\/ane.0000000000004099","relation":{},"ISSN":["0003-2999"],"issn-type":[{"value":"0003-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]}}}